These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38364830)

  • 21. Chlorpromazine for the treatment of migraine in a pediatric emergency department.
    Kanis JM; Timm NL
    Headache; 2014 Feb; 54(2):335-42. PubMed ID: 24512578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The price of pain.
    Rothrock JF
    Headache; 2006 Jun; 46(6):1011. PubMed ID: 16732848
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacotherapeutics of migraine and the blood-brain barrier: serendipity, empiricism, hope, and hype.
    Gupta VK
    MedGenMed; 2006 Jun; 8(2):89. PubMed ID: 16926828
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacotherapy failure and progression to botulinum toxin injection in vestibular migraine.
    Liu YF; Macias D; Donaldson L; Dornhoffer JR; Rizk HG
    J Laryngol Otol; 2020 Jul; 134(7):586-591. PubMed ID: 32713357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistant and refractory migraine: clinical presentation, pathophysiology, and management.
    Ornello R; Andreou AP; De Matteis E; Jürgens TP; Minen MT; Sacco S
    EBioMedicine; 2024 Jan; 99():104943. PubMed ID: 38142636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of children treated with intravenous prochlorperazine for migraine in a pediatric emergency department.
    Trottier ED; Bailey B; Dauphin-Pierre S; Gravel J
    J Emerg Med; 2010 Aug; 39(2):166-73. PubMed ID: 19150192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of migraine prophylaxis treatments for treatment-naïve patients and those with prior treatment failure: a protocol for systematic review and network meta-analysis of randomised controlled trials.
    Numthavaj P; Anothaisintawee T; Attia J; McKay G; Thakkinstian A
    BMJ Open; 2024 Mar; 14(3):e077916. PubMed ID: 38431293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Mixing triptans": patient satisfaction.
    Rothrock JF; Morey V
    Headache; 2011 Jan; 51(1):135-40. PubMed ID: 21198574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-Responders to Treatment With Antibodies to the CGRP-Receptor May Profit From a Switch of Antibody Class.
    Ziegeler C; May A
    Headache; 2020 Feb; 60(2):469-470. PubMed ID: 31872439
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study.
    Reuter U; Goadsby PJ; Lanteri-Minet M; Wen S; Hours-Zesiger P; Ferrari MD; Klatt J
    Lancet; 2018 Nov; 392(10161):2280-2287. PubMed ID: 30360965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic strategies in migraine patients with mood and anxiety disorders: physiopathological basis.
    Casucci G; Villani V; Finocchi C
    Neurol Sci; 2010 Jun; 31 Suppl 1():S99-101. PubMed ID: 20464595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of eletriptan in acute migraine: primary care for Excedrin nonresponders.
    Diamond ML; Hettiarachchi J; Hilliard B; Sands G; Nett R
    Headache; 2004 Mar; 44(3):209-16. PubMed ID: 15012657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative Effectiveness of Dopamine Antagonists for Pediatric Migraine in the Emergency Department.
    Sheridan DC; Laurie A; Pacheco S; Fu R; Hansen ML; Ma OJ; Meckler GD
    Pediatr Emerg Care; 2018 Mar; 34(3):165-168. PubMed ID: 27176905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Migraine.
    Silberstein SD
    Lancet; 2004 Jan; 363(9406):381-91. PubMed ID: 15070571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying the factors underlying discontinuation of triptans.
    Wells RE; Markowitz SY; Baron EP; Hentz JG; Kalidas K; Mathew PG; Halker R; Dodick DW; Schwedt TJ
    Headache; 2014 Feb; 54(2):278-89. PubMed ID: 24001117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial.
    Hirata K; Sakai F; Takeshima T; Imai N; Matsumori Y; Yoshida R; Numachi Y; Peng C; Mikol DD; Cheng S
    J Headache Pain; 2021 Sep; 22(1):110. PubMed ID: 34537006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic novelties in migraine: new drugs, new hope?
    Do TP; Guo S; Ashina M
    J Headache Pain; 2019 Apr; 20(1):37. PubMed ID: 30995909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
    Goldstein J; Tiseo PT; Albert KS; Li C; Sikes CR
    Headache; 2006; 46(7):1142-50. PubMed ID: 16866718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary care in a health maintenance organization.
    Cady R
    Cephalalgia; 1999 Jul; 19(6):541-2. PubMed ID: 10523121
    [No Abstract]   [Full Text] [Related]  

  • 40. Triptans in childhood and adolescence.
    Winner P
    Semin Pediatr Neurol; 2001 Mar; 8(1):22-6. PubMed ID: 11332862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.